McKesson (MCK)

• Market cap: $74.9B
• 1 day: -0.96%
• 5 days: -0.49%
• 1 month: 1.98%
• 3 months: -4.86%
• 6 months: 7.07%
• Year to date: 5.56%
• 1 year: 17.79%
• 5 years: 249.62%
• 10 years: 160.08%
• Sector: Healthcare
• Industry: Drugs, Proprietaries & Druggists Sundries

About: McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Employees: 51,000

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

132% more first-time investments, than exits

New positions opened: 220 | Existing positions closed: 95

44% more call options, than puts

Call options by funds: $1.12B | Put options by funds: $774M

15% more capital invested

Capital invested by funds: $55B [Q3] → $63B (+$8.08B) [Q4]

9% more funds holding in top 10

Funds holding in top 10: 33 [Q3] → 36 (+3) [Q4]

3% more funds holding

Funds holding: 1,517 [Q3] → 1,566 (+49) [Q4]

1.0% less ownership

Funds ownership: 86.41% [Q3] → 85.41% (-1.0%) [Q4]

11% less repeat investments, than reductions

Existing positions increased: 529 | Existing positions reduced: 595

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $641 7% upside
• Avg. target: $657 10% upside
• High target: $677 13% upside

5 analyst ratings

• positive: 4 80%
• neutral: 1 20%
• negative: 0 0%

Evercore ISI Group Elizabeth Anderson 51% 1-year accuracy 18 / 35 met price target	13% upside $675	Outperform Maintained	6 Feb 2025
Citigroup Daniel Grosslight 41% 1-year accuracy 9 / 22 met price target	13% upside $677	Buy Maintained	10 Jan 2025
B of A Securities Michael Cherny 67% 1-year accuracy 26 / 39 met price target	9% upside $650	Buy Maintained	6 Jan 2025
Morgan Stanley Erin Wright 50% 1-year accuracy 14 / 28 met price target	7% upside $642	Overweight Maintained	17 Dec 2024
Wells Fargo Stephen Baxter 24% 1-year accuracy 9 / 38 met price target	7% upside $641	Equal-Weight Maintained	13 Dec 2024